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To help uncover the mechanisms underlying the staggered expression of cartilage-specific genes in the
growth plate, we dissected the transcriptional mechanisms driving expression of the matrilin-1 gene (Matn1).
We show that a unique assembly of evolutionarily conserved cis-acting elements in the Matn1 proximal
promoter restricts expression to the proliferative and prehypertrophic zones of the growth plate. These
elements functionally interact with distal elements and likewise are capable of restricting the domain of activity
of a pancartilaginous Col2a1 enhancer. The proximal elements include a Pe1 element binding the chondrogenic
L-Sox5, Sox6, and Sox9 proteins, a SI element binding Nfi proteins, and an initiator Ine element binding the
Sox trio and other factors. Sox9 binding to Pe1 is indispensable for functional interaction with the distal
promoter. Binding of L-Sox5/Sox6 to Ine and Nfib to SI modulates Sox9 transactivation in a protein dose-
dependent manner, possibly to enhance Sox9 activity in early stages of chondrogenesis and repress it at later
stages. Hence, our data suggest a novel model whereby Sox and Nfi proteins bind to conservedMatn1 proximal
elements and functionally interact with each other to finely tune gene expression in specific zones of the
cartilage growth plate.
Sox proteins play critical roles in lineage specification during
development (18, 21, 25). They have an Sry-related high-mo-
bility-group (HMG) box domain, which binds the minor groove
of DNA with low affinity. They may act as architectural pro-
teins to organize transcriptional complexes (25). Three Sox
proteins direct chondrocyte specification and differentiation,
but it is still unclear how they orchestrate the sequential in-
duction of cartilage-specific genes in developing endochondral
bones.
Endochondral bones form through tightly intertwined mor-
phogenetic and differentiation events (11, 20, 24, 37). First,
mesenchymal cells condense, commit to the chondrocyte lin-
eage, and undergo chondrocyte early differentiation to form
cartilage primordia of future bones. They then sequentially
differentiate into proliferating, prehypertrophic, hypertrophic,
and terminal cells and ultimately die to allow replacement of
cartilage by bone. Importantly, the multiple layers of cells that
comprise cartilage primordia proceed through the multiple
steps of differentiation in a staggered manner. They thereby
establish growth plates (GP), i.e., a series of adjacent tissue
zones comprising cells at progressively more advanced stages
of maturation. The process is tightly regulated both spatially
and temporally to allow GP to continue to grow in one end and
to be progressively replaced by bone in the other end through-
out fetal and postnatal growth (24). Bone growth is determined
by the number of cells proliferating in the columnar zone and
progressing toward hypertrophy. It involves complex functional
interactions between fibroblast growth factor (FGF), Ihh, para-
thyroid hormone-related protein (PTHrP), and other factors
and signaling pathways that allow chondrocytes to constantly
modify their gene expression profile (11, 20, 37). Mutations in
these factors and pathways cause severe forms of dwarfism and
skeletal malformation diseases (20, 33). Elucidating the tran-
scriptional mechanisms involved in specifying gene expression
in specific GP zones has thus special importance to allow
development of suitable therapies for such diseases.
The composition of the cartilage extracellular matrix (ECM)
progressively changes from one GP zone to the next. This is
largely due to staggered expression of the genes encoding the
specific components of this matrix (8, 24, 39). Col2a1 (colla-
gen-2 gene) is activated as soon as prechondrocytes differen-
tiate, whereas Agc1 (aggrecan gene) and most other cartilage
ECM genes are turned on in early chondroblasts (24). In con-
trast, Matn1 (matrilin-1 gene) exhibits a narrower spatiotem-
poral activity (30, 31, 39, 42). It has the unique feature of being
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expressed exclusively in the overtly differentiated chondro-
blasts of the columnar and prehypertrophic GP zones (4, 5,
19). Chondrocytes turn all these genes off as they undergo
hypertrophy and then activate Col10a1 (collagen-10 gene).
Sox9, L-Sox5, and Sox6 form a trio of transcription factors
that are both required and sufficient to induce chondrogenesis
(2, 7, 14, 38). Their main functions are to bind and thereby
directly induce activation of Col2a1, Agc1, and several other
cartilage ECM genes (1, 13, 23–26). Sox9 features a family-
specific HMG box DNA-binding domain and a homodimeriza-
tion domain, which mediate its binding to pairs of inverted Sox
motifs (13, 26). It also features a potent transactivation do-
main. L-Sox5 and Sox6 are highly related to each other but
only distantly related to Sox9 through their HMG box domain.
They feature a dimerization domain, distinct from that of Sox9,
and lack a transactivation domain. They bind more-variable
Sox motifs on cartilage-specific enhancers and cooperate with
Sox9 in transactivation by increasing the efficiency of Sox9
binding to its own sites on DNA (13). It remains unknown,
however, whether and how the activity of this Sox trio is con-
trolled to confer markedly different expression patterns on the
various cartilage ECM genes. We used here the Matn1 pro-
moter as a model to reach deeper insight into gene regulation
orchestrated by the Sox trio.
Matrilin-1 (also called cartilage matrix protein [CMP]) be-
longs to a family of multidomain adaptor proteins (10, 22, 44).
It facilitates assembly of the cartilage ECM by forming colla-
gen-dependent and -independent filaments and interacting
with aggrecan. It also forms complexes with biglycan, and
decorin, linking collagen-6 microfibrils to aggrecan and colla-
gen-2 (45). We previously showed that the Matn1 promoter
features several blocks of sequences highly conserved in am-
niotes (34). A 334-bp short promoter is insufficient to direct
reporter gene activity in cartilage in transgenic mice (34) but
can be activated at a low level in the Matn1-specific GP zones
upon addition of an intronic enhancer (19). Stronger activity is
obtained by using a 2-kb promoter with or without the intronic
enhancer (19). These data suggest that the proximal promoter
may contain the cis-acting elements driving Matn1 expression
in the growth plate but requires distal and intronic enhancers
to be activated. This short promoter features highly conserved
promoter element 1 (Pe1), recognized by the Sox trio, and two
silencer elements (SI and SII) binding Nfi proteins (34, 41).
Here we demonstrate that the short promoter has a central
role in conferring on Matn1 its restricted spatiotemporal ex-
pression pattern. We show the respective roles of the Sox-
binding sites in the Pe1 and the Ine elements and Nfi-binding
sites in the SI element. We show that L-Sox5/Sox6 and Nfi
differentially modulate promoter activation by Sox9, according
to the relative levels of the proteins. Our data thereby provide
new insights into the transcriptional mechanisms that underlie
staggered gene expression in the cartilage GP.
MATERIALS AND METHODS
Cell culture. Chicken embryo chondroblasts (CEC) and fibroblasts (CEF) and
mesenchymes were prepared and cultured as described previously (41). Low-
density mesenchyme (LDM) and high-density mesenchyme (HDM) cultures
were made similarly, by plating 1  106 cells and 5  106 cells, respectively, in
35-mm plates containing F-12 medium–Dulbecco’s modified Eagle medium
(DMEM) (1:1; HyClone Laboratories) supplemented with 10% fetal bovine
serum (FBS; Sigma and Gibco Laboratories). COS-7 cells were cultured under
standard conditions. HDM cultures consisting of early proliferative (stage Ia)
chondroblasts and CEC cultures rich in late proliferative (stage Ib) chondro-
blasts express Matn1 at low and high levels, respectively (31, 41, 42). LDM, CEF,
and COS-7 cultures served as Matn1-nonexpressing controls.
Oligonucleotides and plasmid constructions. Nucleotide sequences for wild-
type and mutant versions of Pe1 and SI and consensus HMG and SOX9 com-
petitors were described previously (34, 41). Sequences of oligonucleotides for
wild-type Ine, Ine derivatives, and mutant versions of Ine are depicted in Fig. 3B.
All positions are given in bp from the first T of the chicken Matn1 TATA
motif. The TR70 (2011/67) and NAD1 (334/67) Matn1-LacZ constructs
were reported previously (19, 34). PS-NAD1 was produced by inserting the
2011/948 Matn1 sequence upstream of NAD1. Eight tandem copies of a
48-bp Col2a1 enhancer element (ECol2a1) were inserted upstream of NAD1 to
obtain 8ECol2a1-NAD1. IneM1-TR70 was made by replacing the NAD1 pro-
moter with the 2011/67 fragment of IneM1-AC8Luc (see below).
Luciferase reporters FO15Luc and AC8Luc, driven by the short and long
Matn1 promoters, respectively, as well as Pe1M1-FO15Luc and Pe1M4-
FO15Luc, carrying point mutations in the Sox motif and spacer of Pe1, respec-
tively, were described (34). To produce 8ECol2a1-FO15Luc, eight copies of
ECol2a1 were inserted upstream of FO15Luc. Mutations were introduced into
Pe1, Ine, and SI elements of reporters by PCR-based QuikChange site-directed
mutagenesis (Stratagene) using oligonucleotides carrying the desired mutations.
All constructs were verified by restriction enzyme analysis and DNA sequencing.
Generation and histological analysis of transgenic mice. All animal experi-
ments were conducted according to the ethical standards of the Animal Health
Care and Control Institute, Csongra´d County, Hungary. C57BL/6, CBA, CD-1,
and FVB mice were obtained form Charles River Laboratories, Hungary. Trans-
genic mice were generated essentially as described previously (19). On embry-
onic day 15.5 (E15.5), foster mothers were sacrificed by cervical dislocation and
the transgenes were detected by PCR in founder (G0) embryos. These embryos
were stained with X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside)
and photographed as whole mounts with a Leica MZFLIII stereomicroscope
equipped with a DC300F camera. Cryosections were counterstained with 0.5%
eosin and analyzed using a Nikon Eclipse E600 microscope equipped with Spot
RT Slider camera as described previously (19). Figures were made with Adobe
Photoshop 8.0 and CorelDraw X4 software.
EMSA and supershift experiments. Full-length cDNAs for L-Sox5 and Sox6
were inserted in frame into the pGEX expression vector. Glutathione S-trans-
ferase (GST)-tagged L-Sox5, Sox6, and SOX9 were expressed and purified, and
crude cell extracts were made as described previously (34). Twenty to 30 fmol
end-labeled DNA probes was incubated with 1 to 2.5 g GST-SOX9 or GST–
L-Sox5 or 3 g crude CEC or CEF cell extracts in the presence of 100 to 500 ng
poly(dG-dC)  (dG-dC) and separated on prerun 5% or 6.6% PAGE gel. In
competition electrophoretic mobility shift assays (EMSA), 50- and 500-fold mo-
lar excesses of cold competitors were added. Supershift experiments were per-
formed as described previously (34) using Sox9, L-Sox5, and Sox6 antisera (26).
In vivo footprinting. CEC and CEF cells and HDM cultures were treated
with dimethylsulfate (DMS) or irradiated with UV light and subjected to
genomic footprinting as described previously (34). Briefly, 30 g of in vivo-
and in vitro-treated DNA samples cleaved with piperidine were amplified by
ligation-mediated PCR (LM-PCR) (32) between 227 and 140 using linker
primers LP11 and LP25 and gene-specific nested primers PU1 and PU2
(upper strand), PL1 and PL2 (lower strand), and PU3 or PL3 (hybridization
probe) (34) (see Fig. 4A).
Transient expression assay. CEC, CEF, and COS-7 cells were transfected with
the Ca-phosphate coprecipitation method 4 to 6 h after plating (34, 41). HDM
and LDM cultures were transfected similarly, but 24 h after plating. Briefly, 2 g
(CEC and CEF) or 5 g (HDM, LDM, and COS-7) reporters was added with 0.5
g pRL-TK vector (Promega) as an internal control to correct for transfection
efficiency. Control plates were transfected with FO15Luc. Firefly and Renilla
luciferase activities were measured using Luminoscan Ascent (ThermoLab-
system 2.6) and luciferase assay systems (Promega) 72 h (HDM and LDM) or
48 h (other cells) posttransfection.
Unless indicated otherwise, cotransfections were performed with 2 g or 5
g AC8Luc and increasing amounts (50 to 250 ng) of effector plasmids
pcDNA5UT-FLAG-L-Sox5 (pFSox5) and pcDNA5UT-FLAG-Sox6 (pFSox6)
(26) without or with 250 ng pCDMA-SOX9 (pSOX9) (26). In a typical experi-
ment, 250 ng pSOX9 and 125 ng each of pFSox5 and pFSox6 effector plasmids
were used. Other experiments were performed with 0 to 300 ng effector plasmids
expressing human CTF-1 (pCTF-1) (36) or mouse Nfia, Nfib, Nfic, and Nfix
(pNfia, pNfib, pNfic, and pNfix), homologous to chicken Nfia1.1, Nfib2, Nfic2,
and human NFIX2, respectively (9). Transfection mixtures were adjusted with
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empty vectors to the same amount of total DNA. Luciferase activities were
expressed as fold values relative to that for FO15Luc, taken as 1, unless noted
otherwise. Transfections were performed in duplicate or triplicate and repeated
3 to 10 times with at least two different DNA preparations. Results are presented
as means  standard errors of the means (SEM).
Combined forced expression and Western analysis. To estimate the relative
expression levels of Sox and Nfi proteins, we used pcDNA5UT-FLAG-SOX9
(pFSOX9) (26) and we made pFNfib by inserting fragments of Nfi expression
plasmids (9) into pcDNA5UT-FLAG. COS-7 cells were cotransfected as de-
scribed above with AC8Luc, 1 g pFSOX9, and increasing amounts of effector
plasmids pFSox5 and pFSox6 or pFNfib. Transfected cells were lysed in 100 l
buffer containing 14 mM HEPES (pH 7.9), 1.5 mM MgCl2, 6 mM KCl, 0.44 mM
NaCl, 0.08 mM EDTA, 2.3 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl
fluoride, 10% glycerol, and a protease inhibitor cocktail (Sigma-Aldrich; P2714).
Supernatants were used to measure luciferase activities and in Western blots with
rabbit anti-FLAG (Sigma) antisera.
Statistical analysis was carried out using one-way analysis of variance
(ANOVA) with KyPlot version 2.0 beta 15.
QRT-PCR. Total RNA was isolated from cultured cells using an RNA isola-
tion kit (Macherey-Nagel). Quantitative real-time PCR (QRT-PCR) was per-
formed on a RotorGene 3000 instrument (Corbett Research) with gene-specific
primers and the SYBR green protocol (16). Briefly, 2 g of DNase-treated RNA
was reverse transcribed using the High-Capacity cDNA Archive kit (Applied
Biosystems). Reactions were done with FastStart SYBR green Master mix
(Roche Applied Science) at a primer concentration of 250 nM as follows: 15 s at
95°C and 45 cycles of 95°C for 15 s, 60°C for 25 s, and 72°C for 25 s. The quality
of the reaction was checked by melting temperature analysis. Individual thresh-
old cycle (CT) values were normalized to the average CT values of three internal
control genes (glyceraldehyde 3-phosphate dehydrogenase [GAPDH], 18S
rRNA, and 28S rRNA genes). The final relative gene expression ratios were
calculated as CT values (comparison of the normalized ratios). Gene-specific
primer sequences are shown in Table S1 at http://www.brc.hu/pub/Supplemental
_Material_Nagy_et_al_MCB2010.pdf.
Genome sequence analysis. The MAF format 44-way vertebrate multiple
alignment file of human chromosome 1 was downloaded from the University of
California, Santa Cruz (UCSC), website (http://hgdownload.cse.ucsc.edu
/downloads.html). The corresponding Matn1 promoter region was extracted
from this file using the MAF2FASTA program of the MULTIZ package (http:
//www.bx.psu.edu/miller_lab/) using the corresponding human positions. The Ine
and Pe1 region was extracted and further refined manually. The 75% majority
rule consensus and the sequence logo were generated with the Geneious Pro
program.
RESULTS
Proximal elements restrict spatiotemporal activation of the
Matn1 promoter by homologous and heterologous enhancers.
We previously reported that a LacZ transgene driven by a
Matn1 short promoter (334/67; NAD1) exhibited low ac-
tivity in mouse embryos (34). The addition of the Matn1
2011/948 sequence (PS) markedly increased transgene ac-
tivity (Fig. 1A and B), but this activity remained lower than
that of a transgene harboring the full-length (2011/67;
TR70) promoter (19) (Fig. 1C). Histological analysis revealed
that the transgene activity also increased proximodistally in the
limbs and craniocaudally in the vertebral bodies, as with TR70
(Fig. 1D to L). This activity was restricted to columnar and
prehypertrophic chondrocytes. The 2011/1134 region in-
creased the short promoter activity less markedly than the
2011/948 region but showed similar zonal and proximo-
distal specificity (see Fig. S1 at http://www.brc.hu/pub
/Supplemental_Material_Nagy_et_al_MCB2010.pdf). We
therefore concluded that elements in the 2011 to 334
region enhance the activity but not the tissue specificity of
the Matn1 promoter.
Next we tested activation of the Matn1 short promoter by 8
tandem copies of the pancartilaginous Col2a1 minimal en-
hancer (8ECol2a1-NAD1). Interestingly, 8ECol2a1-NAD1
dramatically differed in its expression pattern from
p3000i3020Col2a1, which contains the Col2a1 promoter and
enhancer (47) (Fig. 2B and C). It was expressed exclusively in
distal structures, like digits, caudal vertebral bodies, and nasal
cartilage and only in columnar and prehypertrophic GP zones
(Fig. 2D to N). Its sporadic or weak activity in epiphyseal and
source chondroblasts and lack of activity in condensed mesen-
chymal cells, perichondrium cells, and prechondrocytes dif-
fered markedly from the high activity of the Col2a1 transgene
in these cells (47, 48). Thus, the Matn1 short promoter inhib-
ited the Col2a1 enhancer in proximal structures and at early
chondrocyte differentiation stages. Even 16 copies of ECol2a1
neither increased the transgene activity nor altered its re-
stricted spatiotemporal expression (data not shown).
To sum up, the Matn1 short promoter plays a critical role in
restricting cartilage-specific expression, and its activity is en-
hanced by distal elements. It is even capable of restricting the
activity of a powerful Sox-driven panchondrocytic Col2a1 het-
erologous enhancer to distal structures and specific GP zones.
The Sox trio binds to the initiator element in vitro. To
uncover the powerful mechanism employed by the Matn1 short
promoter, we dissected its elements. We reasoned that Pe1,
which is the most conserved element in amniotes, could be
involved in Sox-mediated functions, because it bears a palin-
drome resembling the preferred Sox9-binding site (29) (see
Fig. S2B at http://www.brc.hu/pub/Supplemental_Material
_Nagy_et_al_MCB2010.pdf) and because it is recognized by
the Sox trio in vitro and protected in genomic footprinting (34).
In addition, we found two conserved pairs of inverted Sox
motifs in the Ine element of mammals (Fig. 3A; see Fig. S2A
at the URL listed above). The sequence is poorly conserved in
the chicken, but the chicken promoter also features two pairs
of Sox motifs and a conserved GTGCC motif in the Ine ele-
ment and an Nfi site upstream of TATA (Fig. 3A). These
motifs could thus also play conserved regulatory roles.
We delineated the Sox-binding sites of Ine by EMSA using
purified Sox proteins (Fig. 3B to F). GST-fused SOX9, L-Sox5,
and Sox6 efficiently bound Ine in vitro (Fig. 3C and D and data
not shown). Mutations M2 and M5, which disrupted both in-
verted Sox motifs, abolished complex formation, whereas M1
and M3, which disrupted only one Sox motif, had partial effect.
Probes carrying the 5 (Ine5h1) or 3 (Ine3h2) Sox motif
showed weaker binding than Ine (Fig. 3E and F). Mutation M1
less severely reduced complex formation with L-Sox5 than with
SOX9. This was possibly due to the presence of an upstream
Sox-like motif, as mutations in this motif (M6), in the 5 half
site (M7), or in both sites (M6-7) had a more drastic conse-
quence than M1 (Fig. 3E and F). Mutation M2-3 abolished Sox
binding to the 3 site. We concluded that both Sox sites might
be functional and might act cooperatively.
CEC nuclear proteins formed three major complexes with
Ine. Complexes I and II were supershifted with Sox9, L-Sox5,
and Sox6 antibodies (Fig. 3G) and competed with HMG, Sox9,
or ECol2a1 probes (Fig. 3H). They thus likely contain the Sox
trio. In contrast, complex III was not specific to chondrocytes
and did not contain Sox factors (Fig. 3G to I).
Ine3h1, in which the 5 Sox site was mutated, formed two
major CEC nucleoprotein complexes (Fig. 3J). These com-
plexes migrated like complexes II and III, and formation of the
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former one was competed by the HMG probe. As complex I
was neither efficiently disrupted nor formed with Ine3h1, we
concluded that it likely formed on the 5 Sox site. IneM1, which
was mutated in the 5 Sox site, decreased the formation of
complex I (Fig. 3K), as judged by reduced supershift forma-
tion, especially with Sox9 antibody (compare Fig. 3G and L).
Interestingly, a new complex, not supershifted with Sox anti-
bodies, migrated close to or slightly below complex I with
probes IneM1, IneM2, and IneM3 (Fig. 3K to N, arrowheads).
As IneM1 and IneM3 carried an intact Sox site, they efficiently
displaced both the Sox-specific and unrelated complexes of Ine
(Fig. 3J). IneM3, which carried mutations in the 3 Sox site, did
not produce the Sox-specific complex II, but supershifts with
L-Sox5 and Sox6 antibodies indicated that it formed complex I
(Fig. 3K and N). IneM2, however, which carried mutations in
both Sox sites and in the conserved GTGCC motif, neither
formed complexes I to III (Fig. 3K and M) nor competed for
those (Fig. 3J). Complex III may contain the unidentified fac-
tor binding to the GTGCC motif. Supporting this hypothesis,
only complex III efficiently formed with IneM5, which carried
mutations in both Sox sites but had part of the GTGCC motif
intact (Fig. 3K and O).
We concluded that Sox factors cooperatively bind the Ine
5 and 3 Sox sites. SOX9 binds efficiently only when both
sites are intact. Apart from two CEC-specific Sox com-
plexes, an unrelated complex forms on the conserved GT-
GCC motif in mesenchymal cells. This motif is not listed in
the TRANSFAC database and likely interacts with a non-
chondrocytic factor.
Cartilage-specific in vivo occupancy of Ine and SI. To deter-
mine occupancy of the Matn1 promoter in intact cells, we
performed in vivo footprinting. We treated CEC and CEF
genomic DNA with DMS or UV light to modify G residues at
the N-7 position or produce 6-4 photoproducts at TC and CC
dinucleotides, respectively (Fig. 4). Bound proteins blocking
these modifications appeared as footprints on LM-PCR
genomic sequencing ladders compared to LM-PCR of naked
CEC and CEF DNA treated with the same reagents in vitro.
Differences in the modification patterns between the in vivo-
FIG. 1. Upstream elements increase the activity of the Matn1 prox-
imal promoter in vivo. (A) Schematic of PS-NAD1 depicting conserved
DNA blocks (rectangles, diamond, and oval) in the distal and proximal
Matn1 promoter regions. (B and C) Expression of PS-NAD1 (B) and
TR70 (C; 2-kb Matn1 promoter) transgenes in founder embryos (FE)
stained with X-Gal at E15.5. (D to L) Histological analysis of PS-
NAD1 embryo cryosections. In the developing limbs, X-Gal staining
increases proximodistally from humerus (h), ulna (ul), and femur (f) to
radius (ra), tibia (ti), and fibula (fi) and further from carpals (c) and
metacarpals (mc) to phalanges (ph) (D to H). Staining is absent in
cranial (cran) vertebral bodies (vb) but increases from lumbar (lumb)
to caudal (caud) regions (I to K). LacZ activity is restricted to the GP
zones of columnar chondroblasts (cc) and prehypertrophic chondro-
cytes (pc), while it is low or absent in the zones of epiphyseal (ec) and
source chondroblasts (sc) and hypertrophic chondrocytes (hc) (D, G,
and J to L). np, nucleus pulposus; r, rib. Bars, 2 mm (B and C) and 200
m (D to L).
FIG. 2. The short promoter restricts the Col2a1 enhancer activity
in vivo. Schematic (A) and expression (B) of the 8ECol2a1-NAD1
transgene in comparison with the pattern of P3000i3020Col2a1
(C) driven by the Col2a1 promoter and enhancer (47). (D to N)
Histological analysis of 8ECol2a1-NAD1 cryosections. In the develop-
ing limbs (D to I), X-Gal staining is relatively weak in the humerus and
radius but sharply increases toward the distal phalanges. LacZ activity
is completely repressed or limited to a few cells in the cranial and
lumbar vertebral bodies but is high in the caudal ones and in the distal
part of nasal bone (nb) (K to N). Expression is highest, limited to
groups of cells, in the columnar and prehypertrophic zones, but it is
strongly reduced in the source and epiphyseal chondroblasts, except
for sporadic staining in the distal epiphysis of the humerus (D to N). t,
tarsal; mt, metatarsal. Other abbreviations are as defined for Fig. 1.
Bars, 2 mm (B) and 200 m (D to N).
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FIG. 3. Binding of Sox proteins to Ine in vitro. (A) Ine sequences of selected amniotes and the 75% majority rule consensus for amniotes (see
the whole alignment in Fig. S2A at http://www.brc.hu/pub/Supplemental_Material_Nagy_et_al_MCB2010.pdf). TATA and the most conserved
motif are boxed; NFI motifs are in boldface. Positions are given from TATA. Nucleotides fully conserved in mammals or in amniotes are marked
by asterisks at the top and above the consensus sequence, respectively. Arrows and dotted arrows depict motifs similar to the preferred
Sox9-binding site (29) and Sox consensus (21), respectively. Equus_cabal, Equus caballus; Canis_famili., Canis familiaris; Pteropus_v., Pteropus
vampyrus; Myotis_lucif, Myotis lucifugus. (B) Sequences of Ine and its shorter or mutant derivatives. The conserved GTGCC motif, mutant
nucleotides, the 5 (I) and 3 (II) paired Sox sites and unrelated factor-binding site (III) are denoted. (C to F) EMSA of nucleoprotein complexes
formed with purified GST-fused Sox proteins on Ine and its derivatives. (G to O) Binding of CEC nuclear proteins to Ine and Ine mutants.
(G) Supershift analysis with Sox antibodies (Ab). (H) Competition EMSA with 50-, 100-, and 500-fold molar excesses of the indicated cold
competitors. (I) Comparison of CEC and CEF nucleoprotein complexes. (J) Competition EMSA on Ine and Ine3h1 with the cold probes
indicated. (K to O) EMSA (K) and supershifts (L to O) of the wild-type and mutant Ine. The supershifts (asterisks) and new complexes of Ine
mutants (arrowheads) are marked. F, free probe; PI, preimmune serum.
690 NAGY ET AL. MOL. CELL. BIOL.
and in vitro-treated samples indicated in vivo DNA-protein
contacts at specific nucleotides in the promoter area in CEC
cultures (Fig. 4B and C). Protection, combined with hyperre-
activity on the opposite strand, revealed protein binding to the
Sox motifs of Ine and to the conserved TGTGCC motif at the
start site. Both treatments revealed in vivo occupancy at
TATA, at the Nfi contact points of the reported SI element
(41), at putative PEA3, Sp1, and GC-rich motifs downstream
of SI, and in the Nfi spacer region. In contrast, no footprints
were detected in CEF.
In HDM cultures undergoing early chondrogenesis, none or
weak occupancy was seen at TATA, Ine, and SI elements on
days 0 and 2 (Fig. 5A and B). By day 4, however, the 5 Sox site
of Ine started to be occupied and stronger protection was also
observed for the Sox motifs of Pe1 and Nfi contact points of SII
(Fig. 5C and D).
We concluded that the CEC-specific in vivo footprints at
the Ine Sox sites are likely due to stage-specific binding of
Sox proteins. The TGTGCC motif, the Nfi site, and other
potential ubiquitous factor-binding sites near TATA were
also occupied. Gradual protection at the Pe1 and Ine Sox
sites and at SII and SI Nfi sites in HDM culture suggests that
these elements participate in Matn1 activation during chon-
drogenesis.
The Pe1 Sox site and SI Nfi site are indispensable for pro-
moter activation in transiently transfected chondrocytes. To
study the contribution of short promoter elements to promoter
activity, we introduced point mutations into Ine, Pe1, and SI
and measured their effect on the activity of short (FO15Luc)
and long (AC8Luc) promoter constructs. IneM2, which carried
mutations in the Sox- and ubiquitous factor-binding sites of
Ine, and a double Pe1M1/IneM2 mutation most effectively
reduced the activity of the short promoter in CEC (Fig. 6A and
B). The 2011/334 sequence enhanced the short promoter
activity 	19-fold in AC8Luc in CEC but hardly did so in low-
or nonexpressing cultures (Fig. 6C). IneM1, IneM2, and
IneM3 cut the long promoter activity by one half or more in
CEC. The effect of Pe1M4, which carried a mutation in a
factor-binding site in Pe1 (34), was similar, but Pe1M1, in
which the Sox site of Pe1 was disrupted, dropped the long
promoter activity 13-fold, abolishing CEC-specific enhance-
ment from upstream elements. Pe1M1/IneM2 decreased the
activity (P 
 0.05) to a level even closer to that of FO15Luc.
Thus, the Sox sites in Pe1 and Ine are needed to mediate
promoter activation from upstream elements.
Considering that the SI element was protected in genomic
footprinting in CEC culture (Fig. 4) and bound Nfi proteins in
vitro (41), we also mutated its Nfi contact points. Mutation
SI2dm, either alone or in combination with Pe1M1 or Pe1M4,
markedly reduced the short promoter activity in mesenchymal
cells (Fig. 6A and B). This mutation also dropped the long
promoter activity by 10-fold in CEC and similarly in other
cultures, indicating non-tissue-specific inhibition (Fig. 6C).
Double mutation Pe1M1/SI2dm further diminished the activity
(P 
 0.001) to the basal promoter level in mesenchymal cells,
suggesting an additive or synergistic effect. Thus, disruption of
the Nfi site of the SI silencer element abolished both the tissue-
and stage-specific promoter activity.
We concluded that, although Ine recognition by Sox factors
may be involved, Sox factor binding to Pe1 seems to be more
crucial for promoter activation in CEC culture rich in late
proliferative chondroblasts. In addition, binding of the ubiq-
uitous Nfi to SI near the TATA box may be similarly crucial.
The position-specific conservation of motifs similar to the NFI
consensus (35) near TATA in amniotes (see Fig. S2A at http:
//www.brc.hu/pub/Supplemental_Material_Nagy_et_al_MCB2010
.pdf) further supports the importance of SI in the regulation of
the gene. The significant, but less dramatic, effect of other
mutations suggests that the binding of factors to the Pe1 spacer
and to the conserved motif of Ine may also be needed for full
promoter activity.
Sox and Nfi sites of the short promoter are important for
enhancement by ECol2a1. Next we tested the activation of the
FIG. 4. Tissue-specific occupancy of Ine1 and SI in genomic foot-
printing. (A) Schematic depicting the primers used in footprinting and
the short promoter elements. (B) Footprints on the upper DNA
strand. AG and CT are Maxam-Gilbert ladders. DNA from CEC and
CEF cultures treated in vivo (v) with DMS (open boxes or solid
triangles) or UV light (open circles or solid diamonds) is compared
with the in vitro (t) DNA samples treated with these reagents after
isolation from CEC and CEF. Differences in the modification patterns
between in vivo and in vitro treatments appear as hyperactivities (solid
diamonds or triangles) or protections (open circles or boxes), revealing
specific in vivo DNA-protein contacts. (C) Summary of in vivo foot-
printing on both strands.
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short promoter by a heterologous cartilage enhancer. Eight
copies of ECol2a1 robustly increased the short promoter activity
in CEC but had no effect in CEF or in HDM cultures consist-
ing of early proliferative chondroblasts (Fig. 6D). Lining up
with transgenic mouse data, these results indicate that the
Matn1 short promoter also restricted the broad cartilage-spe-
cific enhancement by ECol2a1 to late proliferative chondroblasts
in tissue culture.
Mutations Pe1M1, IneM2, SI2dm, and Pe1M1/IneM2 de-
creased the relative activity of 8ECol2a1-FO15Luc by 43.6%,
46.6%, 64.9%, and 78%, respectively, in CEC culture (Fig.
6D). Thus, our data show that, whereas Sox factor binding to
Pe1 is crucial for the interaction between the homologous
distal and proximal promoter elements, Sox9 binding to Pe1
and Ine is less essential for mediating enhancement from
ECol2a1. Disrupting all three Sox sites of Pe1 and Ine or the Nfi
site of SI, however, highly diminished the enhancement, sup-
porting the hypothesis that the short promoter elements may
also interact with the heterologous enhancer via the bound Sox
and Nfi factors.
Dramatic decrease of transgene activity by mutation of the
5 Sox site in Ine. A transgene carrying the IneM1 mutation
displayed very low activity in founder embryos, but this activity
remained restricted to the columnar and prehypertophic GP
zones, as with TR70 (Fig. 7). Thus, consistent with the reduced
Sox-specific complex formation (Fig. 3L), the IneM1 mutation
hampered promoter activation in vivo but did not alter the
zone- and distal structure-dependent expression pattern of the
promoter. The 5 Sox site of Ine is thus needed for optimal
promoter activation in vivo.
Accumulation of Nfi and Sox mRNAs during in vitro chon-
drogenesis. We compared the kinetics of expression of Matn1
and other genes in chondrogenic cultures by QRT-PCR. In
CEFs, the steady-state mRNA levels of Matn1 and the Sox trio
were very low, while those for Nfi, but not Nfic, were elevated
relative to those in the committed mesenchyme (HDM, day 0)
FIG. 5. Slow gradual occupancy of the short promoter elements during chondrogenesis. Shown is a comparison of in vivo footprints formed with
DMS in the vicinity of the Ine (A) and Pe1 elements (C) in CEC and in day 0, 2, and 4 HDM cultures. (B and D) Summary of in vivo footprinting
on both strands. Other symbols are as in Fig. 4.
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(Fig. 8A to C). In HDM culture, the Col2a1 mRNA level
slowly but continuously accumulated during differentiation,
whereas the Matn1 mRNA level dramatically increased be-
tween days 2 and 4 (Fig. 8A). Upon differentiation of CEC, the
Col2a1 and Matn1 relative mRNA levels rose to values of
181-fold and 2,057-fold, respectively. Sox9 and Col2a1 mRNAs
accumulated with similar kinetics, but the low levels of L-Sox5
and Sox6 mRNAs increased sharply only in CEC culture, ex-
cept for a small, transient boost of Sox6 mRNA at days 3 and
4 in HDM culture, just preceding the first peak in the Matn1
mRNA level (Fig. 8B). The relative Nfi mRNA levels also
increased transiently by 2.6- to 22-fold, with two peaks at
day 4 and days 6 and 7 in HDM culture, followed by a sharp
decline in CEC culture to close to 1 (Nfia and Nfix) or below
1 (Nfib and Nfic) (Fig. 8C).
Thus, CEC culture, rich in late proliferative chondroblasts,
is characterized by high Matn1 and Sox trio levels but low Nfi
mRNA levels. However, day 4 HDM culture, consisting of
early proliferative chondroblasts, exhibits high Nfi mRNA lev-
els but lower Matn1, Sox9, and Sox6 mRNA levels and very low
L-Sox5 mRNA expression. Sox6 and Nfi mRNA levels peaked
in HDM culture at the time of Matn1 activation, suggesting a
function in Matn1 regulation.
Dose-dependent synergy of L-Sox5/Sox6 with SOX9. Next,
we assessed activation of the Matn1 long promoter by cotrans-
fected Sox proteins. While SOX9 doubled it, L-Sox5/Sox6 de-
creased the promoter activity by about one-half in mesenchy-
mal cells (Fig. 9A). Coexpression of L-Sox5/Sox6 with SOX9
FIG. 6. Effect of Ine, Pe1, and SI mutations on reporter activities in transfected cells. (A) Schematic of single or double mutations introduced
into the short promoters of reporters FO15Luc, AC8Luc, and 8ECol2a1-FO15Luc driven by the short or long Matn1 promoter or multiple copies
of ECol2a1 fused to the short promoter, respectively, as seen on their full maps (bottom). (B to D) Luciferase activities of wild-type (wt) and mutant
reporters in the low-, high-, and nonexpressing HDM, CEC, and CEF cultures, respectively, are presented as fold values relative to that for
FO15Luc. *, P 
 0.05; **, P 
 0.01; ***, P 
 0.001 (compared with wild-type reporter). nd, not determined.
FIG. 7. Low zonal activity of the IneM1-TR70 transgene. (A to
D) Schematic (A) and low activity of the transgene (B to D). (E to M)
Histological analysis of cryosections. Weak X-Gal staining in the de-
veloping shoulder blade (sb) and limbs slightly increases toward pha-
langes (E to I). The increase is more pronounced from cranial to
caudal vertebral bodies (K to M). Staining is seen in the columnar and
prehypertrophic zones (G, H, and M). For other abbreviations, see the
Fig. 1 legend. Bars, 2 mm (B to D) and 200 m (E to M).
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greatly or moderately increased the ability of SOX9 to activate
the promoter in CEF and HDM cultures, respectively, but
decreased it in CEC culture. This suggests synergy between
Sox proteins at early differentiation stages. When we intro-
duced a constant amount of pSOX9 and increasing amounts of
pSox5 and pSox6 expression plasmids into CEF, LDM, and
HDM cultures, synergistic activation peaked at a low ratio of
pL-Sox5 and pSox6 versus pSOX9 and declined at an elevated
ratio (Fig. 9B). Highest activation was seen in CEF (3.5-fold),
followed by that in LDM and HDM cultures in inverse corre-
lation with the endogenous Sox5 and Sox6 expression levels of
these cultures (Fig. 8B), raising the possibility that L-Sox5/
Sox6 may modulate the activation by SOX9 in a dose-depen-
dent manner.
This hypothesis was confirmed by forced expression of the
FLAG-tagged Sox trio in nonchondrocytic COS-7 cells and
monitoring of protein expression in Western blots (Fig. 9C).
Despite the small effect of SOX9 alone, L-Sox5/Sox6 syner-
gized with SOX9 to activate the long promoter up to 	18- to
20-fold at low molar excess. The activation was high from a 1:1
to 4:1 molar ratio of L-Sox5/Sox6 to SOX9 in repeated exper-
iments, but the synergy dropped above a 5:1 molar ratio (Fig.
9C). When tested individually, L-Sox5 and Sox6 had similar
effects (see Fig. S3 at http://www.brc.hu/pub/Supplemental
_Material_Nagy_et_al_MCB2010.pdf).
We concluded that L-Sox5/Sox6 may finely tune the activity
of the Matn1 promoter by increasing transactivation by SOX9
at a low molar ratio relative to SOX9 (early stages of chon-
drogenesis) and by decreasing transactivation by SOX9 at a
high ratio (late stage).
Pe1 mutation hampers transactivation by SOX9, and Ine
mutation decreases the synergy with L-Sox5/Sox6. Next we
studied the effect of Pe1, Ine, and SI mutations on the activity
of the Sox trio. In COS-7 cells forced to express L-Sox5/Sox6 in
optimal ratio relative to SOX9, the Pe1M1/IneM2 mutation
decreased the synergistic activation of the long promoter by
96.1%, followed by the SI2dm and Pe1M1 mutations (85.5 to
89%) (Fig. 9D). The former mutations also repressed SOX9-
mediated activation by 	70%. Similar effects were obtained
when L-Sox5/Sox6 was expressed in high excess relative to
SOX9 in LDM and CEC cultures (Fig. 9D). Thus, disruption
of the short promoter Sox sites abolished transactivation by the
Sox trio even when upstream sites were intact. The effect of the
Pe1M1 mutation was milder, suggesting that SOX9 binding to
Pe1 is critical for transactivation by SOX9 in early and late
stages of chondrogenesis.
Ine mutations diminished the synergistic activation of SOX9
with an optimal ratio of L-Sox5/Sox6 in COS-7 cells (Fig. 9D).
In LDM culture, IneM1 and IneM3 abolished AC8Luc activa-
tion by SOX9, while IneM2 and IneM3 affected the synergistic
activation by the Sox trio more drastically than IneM1. In
keeping with the effect of Ine mutations in EMSA, this result
indicates that the 3 Sox site in Ine equally interacts with SOX9
and L-Sox5/Sox6, whereas the 5 site preferably binds SOX9 in
early chondroblasts. IneM1 also hampers activation by SOX9
in CEC culture (Fig. 9D). Notably, mutation of the SI Nfi site
highly decreased SOX9- and Sox trio-mediated promoter ac-
tivation in the cultures tested. The variable effect of Pe1M4
and the small effect of SOX9 in COS-7 cells suggest that
ubiquitous and/or Sox partner factors may also bind the pro-
moter elements.
We concluded that SOX9 binding to Pe1 likely plays a key
role in mediating enhancement from distal elements. Based on
the data, we suggest a model (see Fig. 10D). L-Sox5/Sox6
expressed at a low level and bound to Ine may synergistically
increase activation by Pe1-bound SOX9 in early chondrogen-
esis. Later on, when produced in excess to SOX9, L-Sox5/Sox6
may decrease activation by SOX9, possibly by competing for
binding to the same sites. In addition, Nfi binding to SI and
binding of other factors to Pe1 and Ine may also be needed for
efficient activation.
Nfi proteins modulate promoter activity. Next we studied
the effect of Nfi on AC8Luc activity in cotransfection assays. In
CEC culture, all Nfi proteins, except Nfia at low concentration,
robustly inhibited long promoter activity (Fig. 10A). When
NFI and SOX9 were expressed at an optimal ratio, Nfib and
Nfic decreased significantly transactivation by SOX9, but all
Nfi proteins exerted 74% to 90% repression at higher ratio
(see Fig. S4A at http://www.brc.hu/pub/Supplemental
_Material_Nagy_et_al_MCB2010.pdf). Notably, CTF-1, an
FIG. 8. QRT-PCR analysis of marker gene expression in chondro-
genic cultures. (A to C) Marker mRNA levels were determined during
chondrogenesis in HDM culture at time points indicated relative to the
day 0 values and compared to mRNA levels of high-expressing CEC
and nonexpressing CEF cultures. CT values were normalized and rel-
ative gene expression ratios were calculated according to Materials and
Methods. Relative expression levels (CT) are plotted as log2 ratios.
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isoform of NFIC, only slightly inhibited activation by SOX9
(see Fig. S4B at the URL listed above), suggesting that the
various Nfi splice variants may have different effects. In COS-7
cells, Nfia and Nfib in optimal amounts indeed cooperated with
SOX9 and potentiated its transactivation of the long promoter
(Fig. 10B). The activation, however, declined at higher levels
of Nfia and Nfib. Forced expression of FLAG-tagged proteins
in COS-7 cells revealed that the activation increased up to an
	2:1 molar ratio of Nfib to SOX9 but significantly decreased
above an 	4:1 molar ratio (Fig. 10C).
FIG. 9. Functional importance of Sox-binding sites in cotransfection assays. (A to C) AC8Luc was cotransfected with Sox expression plasmids
in various cultures as indicated. Western analysis with anti-FLAG antibody (C) shows the relative expressions of L-Sox5/Sox6 and SOX9 in the
transfected COS-7 samples. (D) Effect of point mutations on the synergistic activation of the long promoter by L-Sox5/Sox6 and SOX9 coexpressed
at optimal (2.7:1) molar ratio in COS-7 cells and at a higher ratio in LDM and CEC cultures. The schematic indicates factor binding to the short
promoter elements and to the upstream elements (Upe) (not drawn to scale). Thin and thick arrows depict the transcription efficiencies at early
(E) and at late (L) stages of chondrogenesis. Luciferase activities are given as fold values relative to that for AC8Luc. *, P 
 0.05; **, P 
 0.01;
***, P 
 0.001 (compared with the reporter cotransfected with vectors [A to C] or between the cotransfected mutants and the similarly
cotransfected wild-type AC8Luc [D]); #, P 
 0.05; ##, P 
 0.01; ###, P 
 0.001 (compared with the SOX9-cotransfected reporters).
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These data suggest that Nfi proteins may increase or de-
crease SOX9-mediated transactivation of Matn1 depending on
their abundance relative to SOX9 (Fig. 10D). The conservation
of Nfi sites near TATA and Pe1 (see Fig. S2 at the URL men-
tioned in the previous paragraph) underlines the importance of
Nfi proteins in the restricted cartilage-specific expression of
Matn1 in amniotes.
DISCUSSION
By dissecting the control mechanism that directs Matn1 ex-
pression to specific GP zones, this study sheds new light on a
distinctive regulatory network orchestrated by the chondro-
genic Sox trio. Focusing on the role of short promoter ele-
ments, the present work, in line with former reports (19, 34,
41), reveals the following unique features of Matn1 regulation.
(i) Remarkable sequence and positional conservation of prox-
imal (short) and distal promoter elements strongly suggests an
evolutionarily conserved transcriptional mechanism in am-
niotes. (ii) Fundamentally, the proximal promoter is responsi-
ble for conferring spatiotemporal expression. It exerts such a
dominant effect that it is even capable of restricting spatially
and temporally the activity of the otherwise pancartilaginous
Col2a1 enhancer. (iii) This effect is likely due to a unique set of
conserved proximal elements. The Sox site in Pe1, located 95
to 195 bp upstream of TATA, preferably binds SOX9 and is
most crucial for promoter activity, while Sox sites in Ine lo-
cated at the transcription start sites preferably bind L-Sox5/
Sox6 and are also important. An Nfi site in SI near TATA is
also needed for promoter enhancement, and conservation of
Nfi motifs in SII near Pe1 suggests an important function. (iv)
The most highly conserved Pe1 element plays a key role in
SOX9-mediated transactivation from distal DNA elements,
and L-Sox5/Sox6 bound to Ine and Nfi proteins bound to SI
FIG. 10. Modulation of the Matn1 promoter activity by cotransfected Nfi proteins. (A to C) AC8Luc was cotransfected with increasing amounts
of Nfi expression plasmids without or with a constant amount of SOX9 expression plasmids in the cultures indicated. (C) Western analysis was
made with anti-FLAG antibody to determine the relative ratio of Nfib and SOX9 expressed by force at optimal promoter activation. (D) Model
for fine-tuning of the promoter activity by the Sox trio and Nfi. Shown are schematics of factor binding to DNA elements during Matn1 activation
at the onset of chondrogenesis (a), in early (b) and late proliferative chondroblasts (c) at low and optimal occupancy of sites, respectively, and in
the late stage at high occupancy of the Sox (d) or Nfi sites (e). See the text for a detailed description. Symbols are as defined for Fig. 9.
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may modulate transactivation by SOX9 in a dose-dependent
manner and may thereby fine-tune stage-specific promoter ac-
tivity.
Cartilage-specific control elements with functional Sox sites
in other genes in various locations, e.g., intronic, far-upstream,
5 untranslated, or proximal promoter regions, were described
previously (13, 15, 26–28, 46), but none shows similarity to the
Matn1 control region. While the Matn1 short promoter is suf-
ficient to specify the expression pattern of the gene, the Col2a1
promoter has no activity on its own and relies on an intronic
enhancer capable of directing its activity, as well as that of a
heterologous -globin promoter, to all chondrocytic cells and
each GP zone in transgenic mice (47, 48).
Comparison of orthologous promoter regions (known as
phylogenetic footprinting) can reveal conserved motifs with
important regulatory functions (6). As shown, e.g., for the Sox2
locus, conservation of extragenic sequences in amniotes can
more reliably reflect their functional importance in develop-
ment than the higher degree of conservation between mam-
mals (17). A conserved cartilage-specific element has been
identified, however, only in the far-upstream enhancer of the
mammalian orthologs of Agc1, but it is not conserved in am-
niotes (13). Such a high degree of sequence and positional
conservation among chicken and mammalian orthologs (34)
(see Fig. S2 at http://www.brc.hu/pub/Supplemental_Material
_Nagy_et_al_MCB2010.pdf) has not been found for other car-
tilage ECM genes, strongly suggesting a distance-dependent
important function for Pe1 and Ine in amniotes. Pe1 and Ine
include one or two pairs of oppositely oriented motifs sharing
6/10 to 8/10 or 5/10 to 7/10 nucleotide identity, respectively,
with the preferred Sox9-binding site (29), while Sox9 sites of
cartilage enhancers share only 4 or 5 nucleotides with the Sox
consensus T/AT/ACAAT/AG (13). In line with our former
report (34), the present mutational and functional data con-
firm the key role of the highly conserved Pe1 in SOX9 binding
and SOX9-mediated enhancement from distal elements. Ine is
less conserved, but it is also needed for high transgene activity.
The 3 paired Sox site of Ine had been shifted to a head-to-
head position in the chicken ortholog, and it seems to interact
rather with L-Sox5/Sox6 in EMSA and forced-expression stud-
ies. Notably, the TATA box also showed similarity to the Sox
consensus in most of the Matn1 orthologs, indicating that,
besides the conserved strong Sox9-binding site of Pe1, weaker
Sox sites, which seem to be more diverged, are clustered near
TATA, while the regulatory module might have been under
evolutionary pressure and thus remained more conserved. To
our knowledge, this is the first report on Sox sites clustered
around the transcription start sites, strongly suggesting their
importance in the assembly of the preinitiation complex (PIC).
Matn1 is regulated differently by the Sox trio than other
cartilage genes (13, 24, 26). Whereas Sox9 is sufficient for the
activation of Col2a1, Agc1, and Crtl1, Sox5 and Sox6 are re-
quired to turn on Matn1, as Matn1 mRNA was not detected in
Sox5/; Sox6/ mice (38). Activation of Sox6 precedes that
of Matn1 in culture, underlining the importance of Sox6 in
turning on Matn1. As in cartilage enhancers or the COMP
promoter (13, 26, 27), L-Sox5 and Sox6 also synergize with
SOX9 in the activation of the Matn1 promoter, but only in the
early stage or at low molar excess. Their role, however, turns to
repression in the late stage or at elevated molar ratio. Thus, in
large excess, L-Sox5 and Sox6 may compete with SOX9 for the
same binding sites, as for oligodendrocyte-specific genes (40).
In agreement with the transient activation of Nfi genes dur-
ing in vitro chondrogenesis, dominant negative mutation of
Nfib interfered with chondrogenesis (43). Overexpression of
Nfib increased Sox9 and Col2a1 expression, but Nfi sites me-
diating this regulation have not been identified. By extending
this and our former studies (41), here we provide the first
evidence that, in addition to the Sox trio, Nfi proteins binding
near TATA may also play a critical role in determining the
chondrocyte stage-specific activity of the Matn1 promoter.
According to our model (Fig. 10D), the special geometric
arrangement of proximal elements may explain the unique
regulation of Matn1, as it allows fine-tuning of the promoter
activity by L-Sox5/Sox6 and Nfi, depending on their abun-
dances relative to that of SOX9. At the onset of chondrogen-
esis, binding of Sox and Nfi proteins might be needed to open
the chromatin structure around TATA (Fig. 10D, a and b).
This hypothesis is based on our observations (34) that in vivo
footprints were absent from the short promoter in the nonex-
pressing CEF and that they gradually appeared in differenti-
ating HDM culture, strongly suggesting that activation of
Matn1 involves regulation at the chromatin level. In fact, the
Nfi sites of SI and SII were not occupied in CEF, although the
Nfi genes are expressed in CEF and Nfi proteins can bind SI
and SII from CEF extracts in EMSA and in vitro footprinting
(41). Based on their interaction with histones (3, 12), Nfi pro-
teins may help disrupt the nucleosome structure during Matn1
activation.
At the early stage of chondrogenesis, when occupancy of the
sites is low and SOX9 is expressed at high molar excess relative
to L-Sox5/Sox6, SOX9 preferably binds Pe1 and the Ine-bound
L-Sox5/Sox6 synergizes with SOX9 by likely increasing its ef-
ficiency for binding Pe1 (Fig. 10D, b). L-Sox5/Sox6 similarly
secures Sox9 binding to the Agc1 and Col2a1 enhancers (13).
Binding of Sox factors in the vicinity of TATA may bend the
DNA and facilitate the binding of TATA-binding protein
(TBP) and polymerase II during the assembly of PIC (see also
Fig. S5 at http://www.brc.hu/pub/Supplemental_Material_Nagy
_et_al_MCB2010.pdf). Clustering of Sox motifs in Ine may
increase the probability of L-Sox5/Sox6 binding and help re-
cruit SOX9 to Pe1 and TBP to TATA. Bending the DNA may
also promote the binding of unidentified factors to Pe1 and
Ine. Based on preliminary analysis of mutations, these factors
may affect proximodistal transgene activity (data not shown).
Further, as NFI proteins can activate transcription through
direct interaction with basal transcription factors (e.g., CTF-1
with TFIIB and TBP via its proline-rich transactivation do-
main) and various coactivators and corepressors (12), Nfi bind-
ing to SI (and also possibly to SII near Pe1) may also help the
assembly of PIC and the enhanceosome, thus highly contrib-
uting to activated transcription (see Fig. S5 at the URL listed
above). Pe1 likely plays central role in enhanceosome forma-
tion and in SOX9-mediated promoter activation from distal
elements, but, due to the low abundance of transcription fac-
tors, the transcription activity is low in early proliferative chon-
droblasts (Fig. 10D, b). The promoter activity is highest in late
proliferative chondroblasts, when in vivo occupancy is optimal,
high at Pe1, and Ine, and moderate at SI (Fig. 10D, c). Nfib
exerted activation at an early stage in this study and another
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study (43), but we cannot exclude the possibility that another
Nfi isoform is active in CEC culture, considering the drop in
the relative expression level of Nfib and other Nfi mRNAs. At
this late stage, when the Sox trio mRNA level is elevated,
forced expression of L-Sox5/Sox6 in large molar excess to
SOX9 can decrease transactivation by SOX9, possibly by com-
peting with SOX9 for binding Pe1 and other elements (Fig.
10D, d). High occupancy of the Sox sites of Ine may even
physically interfere with the recruitment of PIC to TATA.
Overproduction of Nfi may also decrease promoter activity due
to competition between activator (e.g., NfIb) and repressor Nfi
isoforms, which may even sterically block TBP binding to
TATA (Fig. 10D, e).
The unique molecular mechanism described here can facil-
itate the construction of GP zone-specific vectors and the de-
velopment of biotechnological therapies for skeletal diseases.
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